Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,155 | -17,108 | -11,689 | -5,495 | -22,181 |
| Depreciation Amortization | 1,169 | 892 | 578 | 281 | 1,114 |
| Accounts receivable | -2,428 | -690 | -607 | -564 | -467 |
| Other Working Capital | -3,223 | 269 | -127 | -579 | -874 |
| Other Operating Activity | 4,062 | 1,660 | 1,832 | 882 | 4,138 |
| Operating Cash Flow | $-23,575 | $-14,977 | $-10,013 | $-5,475 | $-18,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,304 | -1,076 | -494 | -298 | -824 |
| Investing Cash Flow | $-1,304 | $-1,076 | $-494 | $-298 | $-824 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 717 |
| Common Stock Issued | 26,932 | 19,894 | 19,808 | 19,993 | 23,061 |
| Other Financing Activity | -1,414 | -1,414 | -1,414 | -1,414 | -568 |
| Financing Cash Flow | $25,518 | $18,480 | $18,394 | $18,579 | $23,210 |
| Beginning Cash Position | 10,849 | 10,849 | 10,849 | 10,849 | 6,733 |
| End Cash Position | 11,488 | 13,276 | 18,736 | 23,655 | 10,849 |
| Net Cash Flow | $639 | $2,427 | $7,887 | $12,806 | $4,116 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,575 | -14,977 | -10,013 | -5,475 | -18,270 |
| Capital Expenditure | -1,304 | -1,076 | -494 | -298 | -824 |
| Free Cash Flow | -24,879 | -16,053 | -10,507 | -5,773 | -19,094 |